Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?
スポンサーリンク
概要
- 論文の詳細を見る
Positron emission tomography (PET)/computed tomography (CT) with (18)F-fluorodeoxyglucose is widely used for post-therapeutic surveillance of malignant lymphoma. Debate still exists as to whether intravenous contrast media during the CT stage of a PET/CT scan should be used. The purpose of this study was to investigate the clinical value of contrast agent in PET/CT in patients with lymphoma following treatment.
論文 | ランダム
- 直撃インタビュー 電機連合中央執行委員長 古賀伸明氏に聞く 単一市場、グローバル化に対応しうる働き方の改革を!
- この人と30分 電機連合 中央執行委員長 古賀伸明
- 車体造形システム (設計・生産技術) -- (設計・生産技術とCAE)
- 『イン・カントリー』とベトナムメモリアル
- Hepatitis associated antigen in various clinical conditions especially in primary hepatoma and metastatic liver cancer